Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Harvard Business School
Boehringer Ingelheim
Dow
Express Scripts
AstraZeneca
Mallinckrodt

Last Updated: October 18, 2019

DrugPatentWatch Database Preview

Drugs in Development Information for Psilocybin

See Plans and Pricing

« Back to Dashboard

Development status for investigational drug Psilocybin: Patents, clinical trial progress, indications

Psilocybin is an investigational drug.

There have been 34 clinical trials for Psilocybin. The most recent clinical trial was a Phase 1 trial, which was initiated on March 1st 2018.

The most common disease conditions in clinical trials are Depression, Depressive Disorder, and Disease. The leading clinical trial sponsors are Heffter Research Institute, Johns Hopkins University, and Yale University.

There are six hundred and one US patents protecting this investigational drug and one international patent.

Recent Clinical Trials for Psilocybin
TitleSponsorPhase
A Study of Psilocybin for Major Depressive Disorder (MDD)Bracket GlobalPhase 2
A Study of Psilocybin for Major Depressive Disorder (MDD)The EMMES CorporationPhase 2
A Study of Psilocybin for Major Depressive Disorder (MDD)Usona InstitutePhase 2

See all Psilocybin clinical trials

Clinical Trial Summary for Psilocybin

Top disease conditions for Psilocybin
Top clinical trial sponsors for Psilocybin

See all Psilocybin clinical trials

US Patents for Psilocybin

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Psilocybin   Start Trial Devices and methods for continuous analyte monitoring DexCom, Inc. (San Diego, CA)   Start Trial
Psilocybin   Start Trial Devices and methods for continuous analyte monitoring DexCom, Inc. (San Diego, CA)   Start Trial
Psilocybin   Start Trial Indicator and analytics for sensor insertion in a continuous analyte monitoring system and related methods DexCom, Inc. (San Diego, CA)   Start Trial
Psilocybin   Start Trial Advanced analyte sensor calibration and error detection DexCom, Inc. (San Diego, CA)   Start Trial
Psilocybin   Start Trial Drug device configured for wireless communication Pop Test Abuse Deterrent Technology, LLC (Cliffside Park, NJ)   Start Trial
Psilocybin   Start Trial Personal substance detection field test kit Lindon Group, Inc. (East Providence, RI)   Start Trial
Psilocybin   Start Trial Wearable apparatus for detecting a target substance in a liquid Undercover Colors, Inc. (Raleigh, NC)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Psilocybin

Drugname Country Document Number Estimated Expiration Related US Patent
Psilocybin European Patent Office 3069279 2033-11-14   Start Trial
Psilocybin World Intellectual Property Organization (WIPO) 2015073459 2033-11-14   Start Trial
Psilocybin European Patent Office 3069279 2033-11-14   Start Trial
Psilocybin World Intellectual Property Organization (WIPO) 2015073459 2033-11-14   Start Trial
Psilocybin European Patent Office 3068302 2033-11-14   Start Trial
Psilocybin World Intellectual Property Organization (WIPO) 2015073588 2033-11-14   Start Trial
Psilocybin European Patent Office 2697650 2031-04-15   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Medtronic
AstraZeneca
Colorcon
McKinsey
Express Scripts
McKesson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.